Survival (N=136) | HR | 95% CI | Wald-p |
---|---|---|---|
Age | |||
> median | 1.64 | 1.08-2.48 | 0.0199 |
EPHA2 | |||
High vs. Low | 1.67 | 1.05-2.63 | 0.0287 |
EREG | |||
High vs. Low | 0.38 | 0.21-0.66 | 0.0006 |
AREG/KRAS interaction | 7.98 | 2.98-21.40 | <.0001 |
AREG high in KRAS mutant vs | |||
AREG high in KRAS wild type | |||
AREG | |||
AREG high vs. low for KRAS wild type | 0.17 | 0.08-0.34 | <.0001 |
AREG high vs. low for KRAS mutant | 1.33 | 0.67-2.61 | 0.4165 |
KRAS | |||
KRAS mutant vs. wild type for AREG high | 1.49 | 0.90-2.45 | 0.1184 |
KRAS mutant vs. wild type for AREG low | 0.19 | 0. 08–0.43 | <.0001 |